NEOPLASM MALIGNANT
Clinical trials for NEOPLASM MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM MALIGNANT trials appear
Sign up with your email to follow new studies for NEOPLASM MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug targets tough blood cancers in first human trial
Disease control CompletedThis early-stage trial tested an experimental drug called SAR442257 in 47 adults with relapsed or refractory multiple myeloma or non-Hodgkin lymphoma. The main goals were to find a safe dose and check for side effects. Researchers also looked for signs that the drug might fight t…
Matched conditions: NEOPLASM MALIGNANT
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Antibody-Drug conjugate STRO-002 tested in advanced cancers
Disease control CompletedThis study tested a new drug called STRO-002 in 19 Chinese adults with advanced ovarian, endometrial, or other solid tumors that had not responded to prior treatments. STRO-002 is an antibody-drug conjugate, meaning it combines a targeted antibody with a chemotherapy drug to deli…
Matched conditions: NEOPLASM MALIGNANT
Phase: PHASE1, PHASE2 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC